Induction of Clinical Response Using Rifaximin in Crohn's Disease
This study is ongoing, but not recruiting participants.
First Posted: January 29, 2008
Last Update Posted: August 22, 2017
Valeant Pharmaceuticals International, Inc.
Information provided by (Responsible Party):
Scott Lee, University of Washington
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||December 2017|
|Estimated Primary Completion Date:||December 2017 (Final data collection date for primary outcome measure)|